If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
The clinical data tells a more nuanced story: GLP-1 medications do not uniquely destroy muscle
Other Ingredients: De-ionized Water, Vegetable Glycerin, Malic Acid, Citric Acid, Natural Flavors, Potassium Sorbate (as preservative) and Lemon (Citrus limon) Oil
multiple studies and reviews discuss their regenerative properties
If you ever accidentally inject into muscle rather than subcutaneous fat, the accidentally injected semaglutide into muscle guide explains what to expect and what to do